LUNG FY 2023 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

FY 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$69M+28.0% YoY

Gross Profit

$51M73.9% margin

Operating Income

-$62M-90.2% margin

Net Income

-$61M-88.6% margin

EPS (Diluted)

$-1.60

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$38M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$178M

Total Liabilities

$59M

Stockholders' Equity

$118M

Cash & Equivalents

$84M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$69M	$54M	+28.0%
Gross Profit	$51M	$40M	+27.3%
Operating Income	-$62M	-$59M	-5.6%
Net Income	-$61M	-$59M	-3.3%